Back to Rankings

MDGL

MadrigalF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
MDGL vs peer average
15/100
MDGL vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 6 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GILD is the first available peer comparator.

Large-cap biotech with hepatic/R&D depth; useful comparator for commercialization and regulatory execution.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGILDGilead Sciences
MDGL
Madrigal
GILD
Gilead Sciences
Grade
F
C
Momentum
49
35
Value
41
64
Sentiment
0
61
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs GILD

MDGL / GILD
Grade Position
Below peers
MDGL vs. peer average (F vs. C)
15/100
Momentum
49
MDGL
Value
41
GILD
Sentiment
0
GILD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MDGL
1
GILD
GILD
C
60/100
-2
2
VKTX
VKTX
C
60/100
-2
3
ICLR
ICON Plc Common
C
60/100
-2
4
BMRN
BioMarin Pharmaceutical Inc Common
C
60/100
-2
5
ARWR
Arrowhead Pharmaceuticals Inc Common
A
100/100
-4
GILD is the first peer returned for this comparison set.